What Are the Worst Side Effects of Boniva?

The worst side effects of Boniva (ibandronate) are rare but serious: jawbone death, unusual thighbone fractures, and esophageal ulceration that can lead to bleeding or perforation. Most people tolerate Boniva without major problems, but these severe reactions are the ones worth understanding before you start or continue treatment.

Esophageal Damage

Boniva, like all oral bisphosphonates, directly irritates the lining of the upper digestive tract. The tablet can cause chemical burns to the esophagus if it doesn’t move quickly into the stomach. Reported problems range from inflammation and shallow erosions to full ulcers, sometimes with bleeding. In rare cases, the damage progresses to esophageal stricture (permanent narrowing) or even perforation (a hole through the esophageal wall), both of which are medical emergencies.

This is why Boniva comes with strict instructions: take it first thing in the morning on an empty stomach, swallow it with a full glass of plain water, and stay upright for at least 60 minutes afterward. These steps keep the tablet moving through the esophagus and into the stomach as fast as possible. Lying down, taking the pill with too little water, or eating too soon all increase the risk of the tablet lingering where it can do harm.

Warning signs of esophageal injury include new or worsening heartburn, chest pain, and difficulty or pain when swallowing. If any of these develop, you should stop taking Boniva and get medical attention rather than waiting for the next dose to see if it happens again.

Osteonecrosis of the Jaw

Osteonecrosis of the jaw is a condition where a section of jawbone loses its blood supply and begins to die, leaving exposed bone that won’t heal. It typically happens after a tooth extraction or other dental surgery, though it can occasionally appear on its own. The condition is painful, difficult to treat, and sometimes requires surgery to remove the dead bone.

The good news is that the risk for people taking oral bisphosphonates like Boniva for osteoporosis is very low. According to the American Dental Association, the highest reliable estimate of jawbone osteonecrosis in osteoporosis patients on these drugs is about 0.10%, or roughly 1 in 1,000. That’s far lower than the 1% to 10% rate seen in cancer patients receiving much higher intravenous doses of bisphosphonates for bone metastases. Still, the consequences are serious enough that it’s worth telling your dentist you take Boniva before any invasive procedure.

Atypical Femur Fractures

One of the more alarming risks of long-term Boniva use is an unusual type of thighbone fracture. Unlike typical osteoporosis fractures that happen at the hip joint, these breaks occur along the shaft of the femur, often from minimal trauma like stepping off a curb. On X-rays, they look distinctly different from normal fractures: the break line runs straight across the bone, the outer layer of bone is abnormally thickened, and the bone doesn’t shatter into fragments.

The risk climbs steeply with duration of use. One large study found that compared to non-users, the risk of these atypical fractures was about 9 times higher after 3 to 5 years of bisphosphonate use, and over 43 times higher after more than 8 years. This is a major reason many doctors recommend a “drug holiday” after 3 to 5 years of treatment, reassessing whether you still need the medication.

The reassuring finding is that the risk drops quickly after stopping the drug. Many of these fractures also give a warning sign: a dull, aching pain in the thigh or groin that develops weeks or months before the bone actually breaks. That prodromal pain is worth paying attention to, because catching the problem early with imaging can prevent a complete fracture.

Severe Musculoskeletal Pain

Some people develop intense bone, joint, or muscle pain after starting Boniva. This isn’t the mild achiness that many medications cause. The FDA has flagged bisphosphonates specifically for severe, sometimes incapacitating musculoskeletal pain that can start days, months, or even years into treatment. The onset is unpredictable, and the pain can affect the back, limbs, or joints.

For most people who experience this, the pain improves after stopping the medication, though not always completely or immediately. It’s easy to dismiss new aches as just part of getting older, especially since Boniva is typically prescribed to postmenopausal women who may already have joint stiffness. But if you notice a significant change in pain levels after starting Boniva, it’s worth flagging rather than pushing through it.

Kidney Problems

Boniva is cleared from the body through the kidneys, and it can worsen kidney function in people who already have impairment. The injectable form of Boniva is not recommended for anyone whose kidneys filter below 30 mL per minute, a threshold that indicates severe kidney disease. Even the oral tablet requires caution in people with reduced kidney function, because the drug accumulates when the kidneys can’t clear it efficiently. If you have known kidney disease, your doctor should be checking kidney function before and during treatment.

Low Blood Calcium

Boniva works by slowing the breakdown of bone, which also slows the release of calcium from bone into the bloodstream. In people who already have low calcium levels or low vitamin D, this can push blood calcium dangerously low. Symptoms of low calcium include muscle cramps, numbness or tingling in the fingers and around the mouth, and in severe cases, heart rhythm problems. Any existing calcium or vitamin D deficiency needs to be corrected before starting Boniva, not after symptoms appear.

How Common vs. How Serious

It helps to separate the side effects you’re likely to feel from the ones that are rare but dangerous. The everyday side effects, things like heartburn, back pain, and mild flu-like symptoms, are relatively common and usually manageable. The serious risks covered above are uncommon to rare, but they carry real consequences when they do occur.

The pattern that emerges is that short-term use of Boniva carries mostly digestive risks, while the truly worrisome complications like atypical fractures and jawbone death are tied to longer use. That’s why duration of treatment matters so much, and why the decision to stay on Boniva beyond a few years deserves a deliberate conversation rather than just automatic refills.